Regulation of cytoplasmic dynein in vivo
体内细胞质动力蛋白的调节
基本信息
- 批准号:10475621
- 负责人:
- 金额:$ 38.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAmyotrophic Lateral SclerosisAreaAspergillusAspergillus nidulansBrainCell SurvivalCellsCessation of lifeCollaborationsComplexDataDevelopmentDynein ATPaseEarly EndosomeEukaryotic CellGeneticIn VitroKinesinLIS1 proteinLocationMental RetardationMessenger RNAMicrotubulesMinus End of the MicrotubuleMoldsMolecular ConformationMotorNeurodegenerative DisordersNeuronsOrganellesPhysiologicalPlus End of the MicrotubuleProcessProteinsProteomicsRegulationResearchScientistSystemVesicleVirionVirus DiseasesWorkdevelopmental diseasedynactinexperimental studygenome sequencinghuman diseasein vivoinsightlissencephalylive cell imagingprematurepreventtherapy developmentwhole genome
项目摘要
Project Summary/Abstract
We study a microtubule motor called cytoplasmic dynein-1 (or “dynein” for simplicity). In
eukaryotic cells, microtubules serve as tracks for motor proteins such as dynein and kinesins to
move on. These motor proteins deliver cargoes, including organelles, vesicles, proteins, and
mRNAs, to different cellular locations for function. A microtubule has two different ends: the plus
end facing cell periphery and the minus end close to the cell center. Dynein is a minus-end-
directed motor, and it transports cargoes from the cell periphery toward the cell center. Besides
the physiological cargoes including early endosomes and other organelles/vesicles, dynein also
transports virus particles inward after viral infection. Our lab uses a filamentous fungus called
Aspergillus nidulans as a genetic system to study how dynein activities in live cells are
controlled by other proteins. We and other scientists have found that dynein gets transported by
a kinesin to the microtubule plus end where it interacts with early endosome via adapter
proteins such as the HookA complex and the dynactin complex. In live cells, these adapter
proteins are required for activating dynein to move toward the microtubule minus end. However,
this process also requires other proteins such as LIS1 (Lissencephaly-1) and VezA (a vezatin-
like protein). LIS1 promotes an “open” conformation of dynein to facilitate its activation, but the
mechanism of VezA is unclear. Our preliminary data also suggest that negative regulators are
needed to prevent dynein from moving away from the plus end prematurely without carrying its
cargo, but the negative regulators remain to be identified. Moreover, it is unclear what factors
regulate cargo release at the microtubule minus end. In the next five years, we will combine
classical genetics, live cell imaging with whole genome sequencing to identify both positive and
negative regulators of dynein activities. We will also use live cell imaging, proteomics and
structural analysis to solve the mechanisms of VezA and newly identified regulators. The
Aspergillus genetic system is best suited for these studies. While in vitro experiments are
excellent for studying known proteins, our genetic system has the power for discovering
unknown regulators. Discovering these regulators will pave the ways leading to new areas of
research in the field, which will stimulate further work involving collaborations to gain
mechanistic insights into the intricate regulation of the dynein motor.
.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIN XIANG其他文献
XIN XIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIN XIANG', 18)}}的其他基金
Dissecting the interaction between dynein and early endosomes
剖析动力蛋白和早期内体之间的相互作用
- 批准号:
8087258 - 财政年份:2011
- 资助金额:
$ 38.12万 - 项目类别:
Dissecting the interaction between dynein and early endosomes
剖析动力蛋白和早期内体之间的相互作用
- 批准号:
8725190 - 财政年份:2011
- 资助金额:
$ 38.12万 - 项目类别:
Dissecting the interaction between dynein and early endosomes
剖析动力蛋白和早期内体之间的相互作用
- 批准号:
8321957 - 财政年份:2011
- 资助金额:
$ 38.12万 - 项目类别:
Dissecting the interaction between dynein and early endosomes
剖析动力蛋白和早期内体之间的相互作用
- 批准号:
8536861 - 财政年份:2011
- 资助金额:
$ 38.12万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 38.12万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 38.12万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 38.12万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Operating Grants